In COVID-19 patients, a polyclonal anti-RBM436-507 antibody response with IgM, IgG and IgA isotypes was detected in one third of the cases, in amounts correlated with the level of anti-RBD and anti-S antibodies. The gene discussed is CD79A; the disease is COVID-19.